机译:Covid-19中Lopinavir和Ritonavir的异常实验室发现和血浆浓度监测
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
Amiens Univ Hosp Dept Infect Dis Amiens France;
Amiens Univ Hosp Dept Infect Dis Amiens France;
Jules Verne Univ Picardie AGIR EA 4294 Amiens France;
Amiens Univ Hosp Dept Intens Care Amiens France;
Amiens Univ Hosp Dept Anaesthesiol &
Crit Care Med Amiens France;
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
Amiens Univ Hosp Dept Clin Pharmacol Amiens France;
adverse drug reactions; antiretroviral drug; hepatotoxicity; pharmacovigilance; therapeutic drug monitoring;
机译:Covid-19中Lopinavir和Ritonavir的异常实验室发现和血浆浓度监测
机译:通过HPLC-MS / MS同时测定HIV感染患者血浆中的拉米夫定,洛匹那韦,利托那韦和TI同时测定拉米夫定,洛匹那韦,利托那韦和齐多夫定的浓度
机译:洛匹那韦/利托那韦相关脂质的升高与洛匹那韦或利托那韦血浆浓度无关。
机译:洛匹那韦联合利托那韦在人体内的药代动力学模型
机译:用于从人血浆中同时测定抗逆转录病毒药物阿扎那韦,达鲁那韦,依非韦伦,依曲韦林,洛匹那韦,拉格列韦,利托那韦的UPLC-MS / MS方法的验证。
机译:Lopinavir-Ritonavir单药治疗HIV-1感染患者的Lopinavir血浆浓度和病毒学结果
机译:Covid-19中Lopinavir和Ritonavir的异常实验室发现和血浆浓度监测
机译:评估用作实验室等离子体源的异常辉光放电